Alexion Pharmaceuticals Inc (ALXN)

This biotech firm goes after the heavy hitters of the disease world: leukemia, cancer, and asthma in its drug development department.

Show Chart

Events

  • February152012
    Alexion Pharmaceuticals, Inc. Presents at Leerink Swann LLC's 2012 Global Healthcare Conference, Feb-15-2012
  • May 72012
    Alexion Pharmaceuticals, Inc. Presents at Deutsche Bank Securities' 37th Annual Health Care Conference, May-07-2012

Members who own this company also own

the fun, safe & free way to learn the stock market Free! Sign up now! or log in

Current price per share

Today's gain: $3.57 (4.70%)

Is this a fair price given publicly available information?
(Not an indicator of whether the price will go up or down.)
Close Icon

Sign up or Sign in or continue to Explore We Seed